Bendamustine combined with pomalidomide and dexamethasone in relapsed multiple myeloma with extramedullary disease:a multicenter study

Objective To evaluate the efficacy and safety of bendamustine combined with pomalidomide and dexamethasone(BPD regimen)in the treatment of relapsed multiple myeloma(MM)with extramedullary disease.Methods This open,single-arm,multicenter prospective cohort study included 30 relapsed MM patients with extramedullary disease diagnosed in seven hospitals,including Qingdao Municipal Hospital.